Pathologic Response and Survival after Neoadjuvant Chemotherapy with or Without Pertuzumab in Patients with HER2-positive Breast Cancer: the Neopearl Nationwide Collaborative Study
FRONTIERS IN ONCOLOGY(2023)
Key words
pertuzumab,trastuzumab,breast cancer,neoadjuvant chemotherapy,HER-2 positive,real-world data
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined